Bangkok Dusit Medical Services, or BDMS, reported second-quarter net profit for 2026 of 3.25 billion baht, down 6.92% from 3.49 billion baht in the same period last year. Although total operating revenue rose 1% to 27.51 billion baht, it was pressured by operating costs and expenses rising faster than revenue, bringing EBITDA to 6.06 billion baht, down 1%, and the EBITDA margin down to 22.0% from 22.6%. The net profit margin fell to 11.8% from 12.9%. A key pressure came from international patient revenue, which declined 2% after being affected by the Thai-Cambodian border conflict and unrest in the Middle East. Revenue from Cambodian patients fell 67% and from Middle Eastern patients fell 24%, while inpatient revenue declined 1% and the bed occupancy rate dropped to 55% from 61%. Operating expenses including depreciation rose 3% to 23.31 billion baht from 22.66 billion baht, mainly due to higher physician fees, drug and medical supply costs, and depreciation and amortisation from the expansion of the hospital network. However, results were supported by Thai patient revenue rising 2%, and international patient revenue excluding Cambodia and the Middle East still growing as much as 10%, helped by a 42% increase in patients from Myanmar, a 23% increase from the United States, and a 17% increase from Australia. For the first six months of 2026, the company posted net profit of 7.31 billion baht, down 6.76% from 7.84 billion baht in the same period last year, while total operating revenue was 56.07 billion baht, up 1%, and EBITDA was 13.07 billion baht, down 2%.
Bangkok Dusit Medical Services Public Company LimitedQ2 net profit fell 7% on higher costs and lower international patient revenue.
